The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gilad Oren since 2024.
This trader's CIK number is 1929300.
At the time of last reporting, Gilad Oren was the President/CEO of Aprea Therapeutics, Inc.. (stock ticker symbol APRE).
Also see all insider trading activities at Aprea Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | APRE | 5,500 | $10,092 | 0 | $0 | 0 | $0 |
| 2024 | APRE | 3,900 | $20,233 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-03 | APRE | Buy | 5,500 | 1.83 | 10,092 |
| 2024-10-23 | APRE | Buy | 500 | 3.92 | 1,957 |
| 2024-10-15 | APRE | Buy | 250 | 2.90 | 725 |
| 2024-10-10 | APRE | Buy | 150 | 2.54 | 381 |
| 2024-10-14 | APRE | Buy | 1,000 | 2.59 | 2,590 |
| 2024-03-13 | APRE | Buy | 2,000 | 7.29 | 14,580 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gilad Oren (President/CEO of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.